Liat Hayardeny

Liat Hayardeny

Company: Galmed Pharmaceuticals

Job title: Chief Scientific Officer


Exploring Aramchol – Lessons Learned & Optimization Towards Registrational Part of Phase 3 Clinical Study 2:30 pm

• Explaining liver fibrosis – from basic pathophysiology to mechanism of action of drug candidates. • Targeting liver fibrosis: Understanding its main challenges. • Aramchol 101: Discovering its mechanism of action, compound optimization, and resulting clinical efficacy.Read more

day: Day 1 Stream 3 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.